Peter Su

Title: **Peter Su: Innovator in HSV-2 Detection**

Introduction

Peter Su, an esteemed inventor based in Mercer Island, WA, has made significant contributions to the field of immunology. Notably, he holds a patent for innovative methods in the diagnosis of Herpes Simplex Virus Type 2 (HSV-2). His work emphasizes the importance of type-specific detection in serological diagnosis.

Latest Patents

Peter Su's patent focuses on HSV-2 type-specific immunoassays utilizing glycoprotein G2 peptides. This invention centers on peptides derived from the HSV-2 glycoprotein G2, representing unique HSV-2 type-specific epitopes. The patent also details compositions that employ these peptides for precise serological diagnosis of HSV-2 infections. Furthermore, it describes methods for using these peptides to differentiate between HSV-2 and other herpes family viral infections, including HSV-1.

Career Highlights

Peter is currently affiliated with Bio-Rad Laboratories, Inc., a leading company in the life sciences and diagnostics industry. His work is critical in advancing the understanding and detection of HSV-2, contributing to better patient management and treatment options.

Collaborations

Throughout his career, Peter has collaborated with distinguished colleagues, including Peilin Chen and Hao Yu. These partnerships reflect a commitment to excellence and innovation within the research community, particularly in the realm of viral infections and immunology.

Conclusion

Peter Su's inventive contributions underscore the vital role of innovation in healthcare. His patent on HSV-2 type-specific immunoassays represents a significant advancement in diagnostic methodologies, paving the way for enhanced patient outcomes and further research in the field. As the understanding of viral infections evolves, the contributions of inventors like Peter Su continue to be essential in guiding future advancements.